{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:18:53Z","timestamp":1785284333572,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biomaterials.2026.124089","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:50:36Z","timestamp":1771433436000},"page":"124089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A translational systems medicine approach to devising nanotherapeutics for targeted intervention of MASLD"],"prefix":"10.1016","volume":"331","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1154-398X","authenticated-orcid":false,"given":"Zhenyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8371-2749","authenticated-orcid":false,"given":"Mengxuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-6204","authenticated-orcid":false,"given":"Volker M.","family":"Lauschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5505-5188","authenticated-orcid":false,"given":"Ningtao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2026.124089_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124089_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124089_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124089_bib4","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124089_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124089_bib6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124089_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2026.124089_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Pt A","key":"10.1016\/j.biomaterials.2026.124089_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124089_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124089_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156017","article-title":"Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1\u03b1\/XBP1s pathway to inhibit SREBP-1c","volume":"134","author":"Zhao","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124089_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124089_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124089_bib16","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124089_bib17","doi-asserted-by":"crossref","first-page":"14522","DOI":"10.1021\/acsnano.1c04068","article-title":"Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under hypoxia to sensitize immunotherapy","volume":"15","author":"Jiang","year":"2021","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124089_bib18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.7150\/thno.38627","article-title":"Selective intratumoral drug release and simultaneous inhibition of oxidative stress by a highly reductive nanosystem and its application as an anti-tumor agent","volume":"10","author":"Zhu","year":"2020","journal-title":"Theranostics"},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124089_bib19","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s43188-024-00263-y","article-title":"Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK\/AP-1 signaling cascade and ROS production in hepatocytes","volume":"41","author":"Ha","year":"2025","journal-title":"Toxicol. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124089_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042121","article-title":"Alterations of gut microbiota by overnutrition impact gluconeogenic gene expression and insulin signaling","volume":"22","author":"He","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib22","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1038\/s41598-017-06012-6","article-title":"CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP(+)-induced Parkinson's disease model","volume":"7","author":"Jiao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib23","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-17-0151","article-title":"IRS posttranslational modifications in regulating insulin signaling","volume":"60","author":"Peng","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124089_bib24","article-title":"Endoplasmic reticulum stress is involved in glucocorticoid-induced apoptosis in PC12 cells","volume":"2021","author":"Yi","year":"2021","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124089_bib25","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.7150\/ijbs.65044","article-title":"Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies","volume":"18","author":"Fang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124089_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114094","article-title":"TFAP4 regulates the progression of liver fibrosis through the STING signaling pathway","volume":"148","author":"Han","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124089_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/HEP.0000000000001302","article-title":"Pre-B-cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in HSC","volume":"83","author":"Zhao","year":"2026","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124089_bib28","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124089_bib29","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1172\/JCI85506","article-title":"E2f8 mediates tumor suppression in postnatal liver development","volume":"126","author":"Kent","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124089_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124089_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/me.2016-1029","article-title":"Glucocorticoids have opposing effects on liver fibrosis in hepatic stellate and immune cells","volume":"30","author":"Kim","year":"2016","journal-title":"Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124089_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166731","article-title":"Hepatocyte-specific CCAAT\/enhancer binding protein \u03b1 restricts liver fibrosis progression","volume":"134","author":"Yan","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124089_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16234","article-title":"Inhibition of IRE-1\u03b1 alleviates pyroptosis and metabolic dysfunction-associated steatohepatitis by suppressing gasdermin D","volume":"45","author":"Zeng","year":"2025","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124089_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124089_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305300","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Jia","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124089_bib36","article-title":"Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124089_bib37","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1038\/s41467-024-51571-8","article-title":"RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment","volume":"15","author":"Shan","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:26:53Z","timestamp":1779337613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226001134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S0142961226001134"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124089","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A translational systems medicine approach to devising nanotherapeutics for targeted intervention of MASLD","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124089"}}